Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75,119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Dietary treatment and success rate of control in hypercholesterolemia patients treated with lipid lowering drugs: a multi-center study of current status on clinical control of hypercholesterolemia in China].
Wang ZJ, Tian XZ, Li X, Chen Z, Zhao LC, Zhou BF, Wu YF; Current Status in Clinical Control of Hypercholesterolemia in China Research Group. Wang ZJ, et al. Among authors: chen z. Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Apr;33(4):372-5. Zhonghua Xin Xue Guan Bing Za Zhi. 2005. PMID: 15932677 Chinese.
Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults.
Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, Li Y, Rao X, Zhou B, Detrano R, Liu K; USA-PRC Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology Research Group; China Multicenter Collaborative Study of Cardiovascular Epidemiology Research Group. Wu Y, et al. Among authors: chen z. Circulation. 2006 Nov 21;114(21):2217-25. doi: 10.1161/CIRCULATIONAHA.105.607499. Epub 2006 Nov 6. Circulation. 2006. PMID: 17088464
Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS).
Zhao SP, Lu ZL, Du BM, Chen Z, Wu YF, Yu XH, Zhao YC, Liu L, Ye HJ, Wu ZH; China Coronary Secondary Prevention Study (CCSPS). Zhao SP, et al. Among authors: chen z. J Cardiovasc Pharmacol. 2007 Feb;49(2):81-4. doi: 10.1097/FJC.0b013e31802d3a58. J Cardiovasc Pharmacol. 2007. PMID: 17312447 Clinical Trial.
75,119 results
You have reached the last available page of results. Please see the User Guide for more information.